194 related articles for article (PubMed ID: 36481320)
1. Mesenchymal stem/stromal cells from a transplanted, asymptomatic patient with Fanconi anemia exhibit an aging-like phenotype and dysregulated expression of genes implicated in hematopoiesis and myelodysplasia.
Haga CL; Boregowda SV; Booker CN; Krishnappa V; Strivelli J; Cappelli E; Phinney DG
Cytotherapy; 2023 Apr; 25(4):362-368. PubMed ID: 36481320
[TBL] [Abstract][Full Text] [Related]
2. Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production.
Cagnan I; Gunel-Ozcan A; Aerts-Kaya F; Ameziane N; Kuskonmaz B; Dorsman J; Gumruk F; Uckan D
Stem Cell Rev Rep; 2018 Jun; 14(3):425-437. PubMed ID: 29247345
[TBL] [Abstract][Full Text] [Related]
3. Reduced Cell Division Control Protein 42 Activity Compromises Hematopoiesis-Supportive Function of Fanconi Anemia Mesenchymal Stromal Cells.
Xu J; Li X; Cole A; Sherman Z; Du W
Stem Cells; 2018 May; 36(5):785-795. PubMed ID: 29377497
[TBL] [Abstract][Full Text] [Related]
4. Impaired functionality and homing of Fancg-deficient hematopoietic stem cells.
Barroca V; Mouthon MA; Lewandowski D; Brunet de la Grange P; Gauthier LR; Pflumio F; Boussin FD; Arwert F; Riou L; Allemand I; Romeo PH; Fouchet P
Hum Mol Genet; 2012 Jan; 21(1):121-35. PubMed ID: 21968513
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.
Geyh S; Rodríguez-Paredes M; Jäger P; Koch A; Bormann F; Gutekunst J; Zilkens C; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
Haematologica; 2018 Sep; 103(9):1462-1471. PubMed ID: 29773599
[TBL] [Abstract][Full Text] [Related]
6. Clonality studies and N-ras and p53 mutation analysis of hematopoietic cells in Fanconi anemia.
Venkatraj VS; Gaidano G; Auerbach AD
Leukemia; 1994 Aug; 8(8):1354-8. PubMed ID: 8057673
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive characterization of mesenchymal stromal cells from patients with Fanconi anaemia.
Mantelli M; Avanzini MA; Rosti V; Ingo DM; Conforti A; Novara F; Arrigo G; Boni M; Zappatore R; Lenta E; Moretta A; Acquafredda G; de Silvestri A; Cirillo V; Cicchetti E; Algeri M; Strocchio L; Vinti L; Starc N; Biagini S; Sirleto P; Bernasconi P; Zuffardi O; Maserati E; Maccario R; Zecca M; Locatelli F; Bernardo ME
Br J Haematol; 2015 Sep; 170(6):826-36. PubMed ID: 26010568
[TBL] [Abstract][Full Text] [Related]
8. Global miRNA expression of bone marrow mesenchymal stem/stromal cells derived from Fanconi anemia patients.
Cagnan I; Keles M; Keskus AG; Tombaz M; Sahan OB; Aerts-Kaya F; Uckan-Cetinkaya D; Konu O; Gunel-Ozcan A
Hum Cell; 2022 Jan; 35(1):111-124. PubMed ID: 34792755
[TBL] [Abstract][Full Text] [Related]
9. Hematological consequences of a FANCG founder mutation in Black South African patients with Fanconi anemia.
Feben C; Kromberg J; Wainwright R; Stones D; Poole J; Haw T; Krause A
Blood Cells Mol Dis; 2015 Mar; 54(3):270-4. PubMed ID: 25477267
[TBL] [Abstract][Full Text] [Related]
10. Fanconi Anemia Mesenchymal Stromal Cells-Derived Glycerophospholipids Skew Hematopoietic Stem Cell Differentiation Through Toll-Like Receptor Signaling.
Amarachintha S; Sertorio M; Wilson A; Li X; Pang Q
Stem Cells; 2015 Nov; 33(11):3382-96. PubMed ID: 26212365
[TBL] [Abstract][Full Text] [Related]
11. Multiparametric analysis of etoposide exposed mesenchymal stem cells and Fanconi anemia cells: implications in development of secondary myeloid malignancy.
Özdemir C; Muratoğlu B; Özel BN; Alpdündar-Bulut E; Tonyalı G; Ünal Ş; Uçkan-Çetinkaya D
Clin Exp Med; 2023 Dec; 23(8):4511-4524. PubMed ID: 37179284
[TBL] [Abstract][Full Text] [Related]
12. Fanconi anemia and the development of leukemia.
Alter BP
Best Pract Res Clin Haematol; 2014; 27(3-4):214-21. PubMed ID: 25455269
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
[TBL] [Abstract][Full Text] [Related]
14. Improved Hematopoietic Gene Therapy in a Mouse Model of Fanconi Anemia Mediated by Mesenchymal Stromal Cells.
Fernández-García M; Luisa Lamana M; Hernando-Rodríguez M; Sánchez-Domínguez R; Bueren J; Yañez R
Hum Gene Ther; 2018 Mar; 29(3):327-336. PubMed ID: 28816065
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow microenvironment in fanconi anemia: a prospective functional study in a cohort of fanconi anemia patients.
Lecourt S; Vanneaux V; Leblanc T; Leroux G; Ternaux B; Benbunan M; Chomienne C; Baruchel A; Marolleau JP; Gluckman E; Socié G; Soulier J; Larghero J
Stem Cells Dev; 2010 Feb; 19(2):203-8. PubMed ID: 19572808
[TBL] [Abstract][Full Text] [Related]
16. Genetic disruption of both Fancc and Fancg in mice recapitulates the hematopoietic manifestations of Fanconi anemia.
Pulliam-Leath AC; Ciccone SL; Nalepa G; Li X; Si Y; Miravalle L; Smith D; Yuan J; Li J; Anur P; Orazi A; Vance GH; Yang FC; Hanenberg H; Bagby GC; Clapp DW
Blood; 2010 Oct; 116(16):2915-20. PubMed ID: 20606166
[TBL] [Abstract][Full Text] [Related]
17. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.
Faivre L; Guardiola P; Lewis C; Dokal I; Ebell W; Zatterale A; Altay C; Poole J; Stones D; Kwee ML; van Weel-Sipman M; Havenga C; Morgan N; de Winter J; Digweed M; Savoia A; Pronk J; de Ravel T; Jansen S; Joenje H; Gluckman E; Mathew CG
Blood; 2000 Dec; 96(13):4064-70. PubMed ID: 11110674
[TBL] [Abstract][Full Text] [Related]
18. Radiologic differences between bone marrow stromal and hematopoietic progenitor cell lines from Fanconi Anemia (Fancd2(-/-)) mice.
Berhane H; Epperly MW; Goff J; Kalash R; Cao S; Franicola D; Zhang X; Shields D; Houghton F; Wang H; Wipf P; Parmar K; Greenberger JS
Radiat Res; 2014 Jan; 181(1):76-89. PubMed ID: 24397476
[TBL] [Abstract][Full Text] [Related]
19. An abnormal bone marrow microenvironment contributes to hematopoietic dysfunction in Fanconi anemia.
Zhou Y; He Y; Xing W; Zhang P; Shi H; Chen S; Shi J; Bai J; Rhodes SD; Zhang F; Yuan J; Yang X; Zhu X; Li Y; Hanenberg H; Xu M; Robertson KA; Yuan W; Nalepa G; Cheng T; Clapp DW; Yang FC
Haematologica; 2017 Jun; 102(6):1017-1027. PubMed ID: 28341737
[TBL] [Abstract][Full Text] [Related]
20. Associations of complementation group, ALDH2 genotype, and clonal abnormalities with hematological outcome in Japanese patients with Fanconi anemia.
Yabe M; Koike T; Ohtsubo K; Imai E; Morimoto T; Takakura H; Koh K; Yoshida K; Ogawa S; Ito E; Okuno Y; Muramatsu H; Kojima S; Matsuo K; Mori M; Hira A; Takata M; Yabe H
Ann Hematol; 2019 Feb; 98(2):271-280. PubMed ID: 30368588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
